IL124337A - נגזרות פירידו-אוקסזין, תכשירי רוקחות המכילים אותן ושיטה להכנתן - Google Patents

נגזרות פירידו-אוקסזין, תכשירי רוקחות המכילים אותן ושיטה להכנתן

Info

Publication number
IL124337A
IL124337A IL12433796A IL12433796A IL124337A IL 124337 A IL124337 A IL 124337A IL 12433796 A IL12433796 A IL 12433796A IL 12433796 A IL12433796 A IL 12433796A IL 124337 A IL124337 A IL 124337A
Authority
IL
Israel
Prior art keywords
dihydro
compound
yield
found
calc
Prior art date
Application number
IL12433796A
Other languages
English (en)
Other versions
IL124337A0 (en
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of IL124337A0 publication Critical patent/IL124337A0/xx
Publication of IL124337A publication Critical patent/IL124337A/he

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
IL12433796A 1995-11-07 1996-10-17 נגזרות פירידו-אוקסזין, תכשירי רוקחות המכילים אותן ושיטה להכנתן IL124337A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/553,188 US5696117A (en) 1995-11-07 1995-11-07 Benzoxazine antimicrobial agents
PCT/US1996/016669 WO1997017333A1 (en) 1995-11-07 1996-10-17 Benzoxazine antimicrobial agents

Publications (2)

Publication Number Publication Date
IL124337A0 IL124337A0 (en) 1998-12-06
IL124337A true IL124337A (he) 2001-08-08

Family

ID=24208465

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12433796A IL124337A (he) 1995-11-07 1996-10-17 נגזרות פירידו-אוקסזין, תכשירי רוקחות המכילים אותן ושיטה להכנתן

Country Status (24)

Country Link
US (2) US5696117A (he)
EP (1) EP0869949B1 (he)
JP (1) JP2000500134A (he)
KR (1) KR100503910B1 (he)
AR (1) AR004706A1 (he)
AT (1) ATE229944T1 (he)
AU (1) AU720743B2 (he)
BR (1) BR9611400A (he)
CZ (1) CZ137998A3 (he)
DE (1) DE69625515T2 (he)
DK (1) DK0869949T3 (he)
ES (1) ES2188795T3 (he)
HU (1) HUP9901184A3 (he)
IL (1) IL124337A (he)
MX (1) MX9803650A (he)
MY (1) MY128650A (he)
NO (1) NO311026B1 (he)
NZ (1) NZ321251A (he)
PL (1) PL189987B1 (he)
RU (1) RU2191179C2 (he)
SK (2) SK283888B6 (he)
TW (1) TW536537B (he)
WO (1) WO1997017333A1 (he)
ZA (1) ZA969326B (he)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0101110A3 (en) 1997-10-27 2002-06-28 Reddys Lab Ltd Dr Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
US6265401B1 (en) * 1997-10-27 2001-07-24 Reddy-Cheminor, Inc. Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
AU3406599A (en) * 1998-04-09 1999-11-01 Institut Fur Diagnostikforschung Gmbh An Der Freien Universitat Berlin Novel benzyl guanidine derivatives for therapy and (in-vivo) and (in-vitro) diagnosis
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
US6534535B1 (en) 1999-08-12 2003-03-18 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
US6599899B2 (en) 2000-05-12 2003-07-29 Ortho-Mcneil Pharmaceutical, Inc. Benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment
EP1280783A2 (en) * 2000-05-12 2003-02-05 Ortho-McNeil Pharmaceutical, Inc. Methods of treatment using benzoxazinones as peroxisome proliferator activated receptor gamma modulators
PT1280784E (pt) 2000-05-12 2007-09-03 Ortho Mcneil Pharm Inc 4h-benzo [1,4] oxazin-3-onas biologicamente activas.
US6908908B2 (en) 2000-05-12 2005-06-21 Ortho-Mcneil Pharmaceutical, Inc. Biologically active 4H-benzo [1,4] oxazin-3-ones
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
RU2371436C2 (ru) * 2003-09-01 2009-10-27 Оно Фармасьютикал Ко., Лтд. СОЕДИНЕНИЯ НА ОСНОВЕ БЕНЗОКСАЗИНА И ИНДОЛА, ОБЛАДАЮЩИЕ АНТАГОНИСТИЧЕСКИМ ДЕЙСТВИЕМ В ОТНОШЕНИИ РЕЦЕПТОРА cysLT2
BRPI0414487A (pt) * 2003-09-17 2006-11-14 Ono Pharmaceutical Co composto de ácido carboxìlico e composições medicinais contendo os mesmos como o ingrediente ativo
US20050266575A1 (en) * 2004-05-27 2005-12-01 Mayo Kevin H Pharmacophores for nociceptin, methods of obtaining and using in screening for nociceptin mimics
GB0423405D0 (en) * 2004-10-21 2004-11-24 Novartis Ag Organic compounds
WO2006082495A1 (en) * 2005-02-02 2006-08-10 Ranbaxy Laboratories Limited Peroxisome proliferator activated receptor modulators
EP2671507A3 (en) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-informatics system
NZ568050A (en) * 2005-11-24 2010-09-30 Eisai R&D Man Co Ltd Morpholine type cinnamide compound
US20070197512A1 (en) * 2006-01-27 2007-08-23 Japan Tobacco Inc. Carboxylic Acid Compounds and Use Thereof
WO2007086504A1 (ja) * 2006-01-27 2007-08-02 Japan Tobacco Inc. カルボン酸化合物及びその用途
TWI385161B (zh) * 2006-02-02 2013-02-11 Mitsubishi Tanabe Pharma Corp 含氮雜雙環化合物
JP5099814B2 (ja) * 2006-02-02 2012-12-19 田辺三菱製薬株式会社 含窒素複素二環式化合物
WO2007105581A1 (ja) * 2006-03-10 2007-09-20 Yuuzou Tsuchida 抗微生物剤及び抗微生物性組成物
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
TWI410410B (zh) 2007-08-10 2013-10-01 Ono Pharmaceutical Co Phenylacetic acid compounds
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
WO2010119906A1 (ja) * 2009-04-14 2010-10-21 日産化学工業株式会社 ハロアルキルスルホンアニリド誘導体
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US8669363B2 (en) 2011-03-24 2014-03-11 Southern Methodist University Quinoxaline compounds and derivatives
US9493452B2 (en) 2011-03-24 2016-11-15 Southern Methodist University Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors
US9309208B2 (en) 2012-03-23 2016-04-12 Southern Methodist University Methods of making and using thioxothiazolidine and rhodanine derivatives as HIV-1 and JSP-1 inhibitors
GB2533925A (en) * 2014-12-31 2016-07-13 Univ Bath Antimicrobial compounds, compositions and methods
JP7397491B2 (ja) * 2018-10-23 2023-12-13 国立研究開発法人科学技術振興機構 PPARδ活性化剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635956A (en) * 1968-03-01 1972-01-18 Squibb & Sons Inc Benzothiazines related compounds derivatives and salts thereof
US3725403A (en) * 1970-10-20 1973-04-03 Squibb & Sons Inc Benzothiazine derivatives
JPS5547006B2 (he) * 1973-04-04 1980-11-27
FR2588868B1 (fr) * 1985-10-21 1988-11-10 Negma Laboratoires Acyl-7 benzoxazinones et leurs derives, procede pour les obtenir et compositions pharmaceutiques les contenant
EP0233728A1 (en) * 1986-02-11 1987-08-26 Takeda Chemical Industries, Ltd. 1,4-Benzoxazine derivatives their production and use
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
AU5404790A (en) * 1989-04-26 1990-11-16 Upjohn Company, The Antibacterial pyrido(1,2,3-de)-1,4-benzoxazinone agents
FI96313C (fi) * 1990-11-28 1996-06-10 Daiichi Seiyaku Co Menetelmä terapeuttisesti käyttökelpoisten ja optisesti aktiivisten 10-(3-amino-4,4-dialkyyli-1-pyrrolidinyyli)-9-fluori-2,3-dihydro-3(S)-metyyli-7-okso-7H-pyrido/1,2,3-de//1,4/bentsoksatsiini-6-karboksyylihappojen valmistamiseksi
DE4304806A1 (de) * 1993-02-17 1994-08-18 Kali Chemie Pharma Gmbh 5-Phenyl-pyrrolo-1,4-benzoxazin- und -thiazin-Derivate sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
FR2714381B1 (fr) * 1993-12-29 1996-02-02 Pharmascience Lab Dérivés de la benzoxazine, leurs procédés d'obtention et leur utilisation en tant que médicaments .

Also Published As

Publication number Publication date
HUP9901184A2 (hu) 1999-10-28
WO1997017333A1 (en) 1997-05-15
MY128650A (en) 2007-02-28
KR100503910B1 (ko) 2005-12-29
AU720743B2 (en) 2000-06-08
JP2000500134A (ja) 2000-01-11
SK285388B6 (sk) 2006-12-07
NO311026B1 (no) 2001-10-01
SK283888B6 (sk) 2004-04-06
EP0869949B1 (en) 2002-12-18
HUP9901184A3 (en) 2001-11-28
SK59798A3 (en) 1999-09-10
DE69625515T2 (de) 2003-05-15
DE69625515D1 (de) 2003-01-30
ZA969326B (en) 1998-05-06
IL124337A0 (en) 1998-12-06
KR19990067395A (ko) 1999-08-16
TW536537B (en) 2003-06-11
AU7451996A (en) 1997-05-29
NO982071L (no) 1998-06-05
BR9611400A (pt) 1999-08-31
MX9803650A (es) 1998-11-30
NZ321251A (en) 1999-10-28
DK0869949T3 (da) 2003-03-31
PL189987B1 (pl) 2005-10-31
CZ137998A3 (cs) 1998-10-14
RU2191179C2 (ru) 2002-10-20
US5854242A (en) 1998-12-29
PL326704A1 (en) 1998-10-26
US5696117A (en) 1997-12-09
ES2188795T3 (es) 2003-07-01
EP0869949A1 (en) 1998-10-14
ATE229944T1 (de) 2003-01-15
NO982071D0 (no) 1998-05-06
AR004706A1 (es) 1999-03-10

Similar Documents

Publication Publication Date Title
IL124337A (he) נגזרות פירידו-אוקסזין, תכשירי רוקחות המכילים אותן ושיטה להכנתן
US5707990A (en) 2-substituted amino and thio alkyl benzoxazine antimicrobial agents
US20050171101A1 (en) Phenanthridinones as parp inhibitors
US9527867B2 (en) Antibacterial biaromatic derivatives
US5773469A (en) Diaryl antimicrobial agents
US5173486A (en) Dibenz[b,f][1,4]oxazepin-11(10H)-ones for multidrug resistance reversing agents
CA2405532A1 (en) Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
US11548900B2 (en) Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof
AU2006331676A1 (en) Nitroimidazole compounds
WO2000021949A1 (en) Quinolones as t-rna synthetase inhibitors and antibacterial agents
KR20020084274A (ko) 신규한 벤조술탐 옥사졸리디논 항균제
CA2236928A1 (en) Benzoxazine antimicrobial agents
EP0489733A1 (en) Antibacterial pyrido(1,2,3-de)-1,4-benzoxazinone agents
JP3573364B2 (ja) 新規なn−(2−シンナミルアミノエチル)ナフタレンスルフォンアミド誘導体
KR970000950B1 (ko) 벤조헤테로사이클릭화합물의 제조방법
CN119173511A (zh) 苯并三唑化合物

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees